View Financial HealthFull Alliance Group 배당 및 자사주 매입배당 기준 점검 0/6Full Alliance Group 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공지 • Aug 08Full Alliance Group, Inc. Announces That Its Qubitera Holdings Subsidiary Is Developing Breakthrough Technology That Will Help Hospitals and Healthcare Systems Share Patient Information Safely and InstantlyFull Alliance Group, Inc. announced that its Qubitera Holdings subsidiary is developing breakthrough technology that will help hospitals and healthcare systems share patient information safely and instantly. The Quant Blockchain platform is being built to solve a major problem: hospitals currently waste billions of dollars each year because their computer systems can't talk to each other. Right now, when a patient visits different doctors or hospitals, their medical records often get stuck in separate systems. Doctors waste time calling other offices, sending faxes, or asking patients to carry paper records between visits. This costs healthcare organizations about 8% of their total budgets - roughly $77.8 billion wasted every year. New federal rules require all healthcare systems to connect their computer systems by January 2027, creating urgent demand for solutions like Quant Blockchain. Quant Blockchain is being designed as a secure digital highway that will let different hospital computer systems share patient information instantly: Safe and Legal: Meets all healthcare privacy laws (HIPAA compliance); Works with Existing Systems: Hospitals don't need to replace their current software; Instant Sharing: Patient records transfer in seconds instead of hours or days; Smart Technology Ready: Designed to work with artificial intelligence tools that help doctors make better decisions. The Company is targeting several fast-growing markets: Healthcare Data Sharing Market: Growing from $84.58 billion in 2025 to $352.13 billion by 2032; Healthcare Blockchain Technology: Expected to reach $178.91 billion by 2034; Hospital AI Systems: Need instant access to patient data to work properly. Next Steps: Qubitera Holdings is working with select hospitals to test the system before the 2027 deadline. The company expects to announce partnerships with major healthcare systems as more hospitals prepare for the new requirements. Quant Blockchain works alongside Full Alliance Group's other products, including the YAHBEE Wallet for digital payments and QUBEE HIVE HOLDINGS for financial services.공지 • Mar 13Full Alliance Group, Inc. Announces Craig Lane as President of Its Wholly Owned Subsidiary Dynamaxx Health, IncFull Alliance Group, Inc. announce the appointment of Craig Lane as President of Dynamaxx Health, Inc., a subsidiary dedicated to pioneering advancements in cash pay anti-aging and rejuvenation healthcare. With an extensive background in healthcare management and finance, Craig is perfectly positioned to lead Dynamaxx Health into a future with innovation and growth. Craig brings to the table an impressive repertoire of expertise in healthcare management, sales, and corporate leadership. His career highlights include over a decade of impactful roles at Valet Orthopedics and SurgCap Funding, where he excelled in managing clinics, optimizing revenue cycle management, building clinics, developing financial structures conducive to growth and efficiency, and successfully exiting his own clinics. His achievements are a testament to his leadership and vision, having been named Top Sales Person in the US for Carnation Foods which rewarded Craig for a scholarship at Florida State University, and later, won Entrepreneur of the Year for starting an apparel company as well as pioneering a campus map for new students at no cost by creating a coop advertising model during his MBA studies at the University of South Florida. Craig's tenure as a top commercial banker, managing a portfolio in excess of $100,000,000 and securing the largest loan in the bank's history for an iconic sports team, underscores his financial acumen. Craig was a correspondent with Greystone for multi-family and sub-prime commercial loans. As President of DYNAMAXX Health, Craig's robust background in marketing, finance, and particularly healthcare, will guide the organization toward achieving its goals for expansion and innovation. His capability to manage complex business operations and drive rapid scaling initiatives is crucial for Dynamaxx Health's ambition to become a leading name in providing cash pay medical services through its MAXX Health anti-aging and rejuvenation clinics.공지 • Jun 21Full Alliance Group, Inc. Announces Appointment of Dr. Richard Marc Goldfarb to Medical Advisory BoardFull Alliance Group, Inc. has announced the appointment of Dr. Richard Goldfarb to their medical advisory board. He brings with him over 30 years of experience as a board-certified surgeon and a valuable aesthetics background that will inform and advance the rejuvenative healthcare efforts of the Company, overseeing the clinical studies of its new line of supplements, Natural Powers, and supporting its work on EBO2 protocol. Dr. Goldfarb's extensive clinical experience and research in cosmetics, aesthetics, and surgery will bring a new perspective and innovative ideas to the Company's preventative healthcare technology and nutritional product offerings. FAGI is excited about his input on quality supplement formulas and the aesthetic expertise he will add to acquisition efforts. His long history as a medical director, in addition to his cutting-edge approaches to health enhancement techniques, will provide the Company with a distinct advantage. Dr. Goldfarb will be instrumental in the Company's launch of its Natural Powers ("NP") brand. All supplements and topicals in the NP brand will have clinical studies and will be published in prestigious journals. The initial products in the NP brand will be sleep, immunity, focus, weight loss, and pain. Dr. Goldfarb will be working closely with Steve Kusher, the Company's master formulator, on the formulation of these products. The Company is expecting the first clinical study to begin in third quarter 2023, with the first product being Natural Powers - Sleep.Dr. Goldfarb graduated from the Chicago Medical School with top honors in surgery and completed surgical training at Northeastern Ohio College of Medicine, a Division of the Cleveland Clinic. He received specialized cosmetic surgery training from the University of Pennsylvania'sDepartment of Plastic Surgery and Yale University. He also holds certifications in Advanced Cardiac Life Support Aesthetic Advancements, a certificate from the American Academy of Cosmetic Physicians, and is a long-time Fellow of the American College of Surgeons, among several other accreditations. Currently, Dr. Goldfarb is the medical director for major companies, Benev, and Selphyl.Past Medical Director for The Silhouette Lift, and Viora™. He is also a scientific advisory board member and lecturer for The Aesthetics Show and holds prominent professional society memberships with The American Society of Lasers in Medicine, the American Academy of Liposuction Surgery, the American Academy of Cosmetic Surgery, and many more. Major recognitions that Dr. Goldfarb has garnered include an EmSculpt Ambassador Award from BTL Aesthetics and is currently on the Medical Advisory Board, an award from the Philippine Academy of Aesthetic and Age Management, a recipient of "The Best Surgical Body Shaping" award, and numerous others throughout his long career. He is also the Chief Executive Officer and founder of Progressive Men's Health and is a founding board member, faculty member, and lecturer for the National Society of Cosmetic Physicians, for which he chaired an annual meeting hosting hundreds of physicians from around the globe.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 FAGI 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: FAGI 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Full Alliance Group 배당 수익률 vs 시장FAGI의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (FAGI)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Software)0.9%분석가 예측 (FAGI) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 FAGI 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 FAGI 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 FAGI 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: FAGI 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/11 01:15종가2026/05/11 00:00수익2009/06/30연간 수익2008/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Full Alliance Group, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공지 • Aug 08Full Alliance Group, Inc. Announces That Its Qubitera Holdings Subsidiary Is Developing Breakthrough Technology That Will Help Hospitals and Healthcare Systems Share Patient Information Safely and InstantlyFull Alliance Group, Inc. announced that its Qubitera Holdings subsidiary is developing breakthrough technology that will help hospitals and healthcare systems share patient information safely and instantly. The Quant Blockchain platform is being built to solve a major problem: hospitals currently waste billions of dollars each year because their computer systems can't talk to each other. Right now, when a patient visits different doctors or hospitals, their medical records often get stuck in separate systems. Doctors waste time calling other offices, sending faxes, or asking patients to carry paper records between visits. This costs healthcare organizations about 8% of their total budgets - roughly $77.8 billion wasted every year. New federal rules require all healthcare systems to connect their computer systems by January 2027, creating urgent demand for solutions like Quant Blockchain. Quant Blockchain is being designed as a secure digital highway that will let different hospital computer systems share patient information instantly: Safe and Legal: Meets all healthcare privacy laws (HIPAA compliance); Works with Existing Systems: Hospitals don't need to replace their current software; Instant Sharing: Patient records transfer in seconds instead of hours or days; Smart Technology Ready: Designed to work with artificial intelligence tools that help doctors make better decisions. The Company is targeting several fast-growing markets: Healthcare Data Sharing Market: Growing from $84.58 billion in 2025 to $352.13 billion by 2032; Healthcare Blockchain Technology: Expected to reach $178.91 billion by 2034; Hospital AI Systems: Need instant access to patient data to work properly. Next Steps: Qubitera Holdings is working with select hospitals to test the system before the 2027 deadline. The company expects to announce partnerships with major healthcare systems as more hospitals prepare for the new requirements. Quant Blockchain works alongside Full Alliance Group's other products, including the YAHBEE Wallet for digital payments and QUBEE HIVE HOLDINGS for financial services.
공지 • Mar 13Full Alliance Group, Inc. Announces Craig Lane as President of Its Wholly Owned Subsidiary Dynamaxx Health, IncFull Alliance Group, Inc. announce the appointment of Craig Lane as President of Dynamaxx Health, Inc., a subsidiary dedicated to pioneering advancements in cash pay anti-aging and rejuvenation healthcare. With an extensive background in healthcare management and finance, Craig is perfectly positioned to lead Dynamaxx Health into a future with innovation and growth. Craig brings to the table an impressive repertoire of expertise in healthcare management, sales, and corporate leadership. His career highlights include over a decade of impactful roles at Valet Orthopedics and SurgCap Funding, where he excelled in managing clinics, optimizing revenue cycle management, building clinics, developing financial structures conducive to growth and efficiency, and successfully exiting his own clinics. His achievements are a testament to his leadership and vision, having been named Top Sales Person in the US for Carnation Foods which rewarded Craig for a scholarship at Florida State University, and later, won Entrepreneur of the Year for starting an apparel company as well as pioneering a campus map for new students at no cost by creating a coop advertising model during his MBA studies at the University of South Florida. Craig's tenure as a top commercial banker, managing a portfolio in excess of $100,000,000 and securing the largest loan in the bank's history for an iconic sports team, underscores his financial acumen. Craig was a correspondent with Greystone for multi-family and sub-prime commercial loans. As President of DYNAMAXX Health, Craig's robust background in marketing, finance, and particularly healthcare, will guide the organization toward achieving its goals for expansion and innovation. His capability to manage complex business operations and drive rapid scaling initiatives is crucial for Dynamaxx Health's ambition to become a leading name in providing cash pay medical services through its MAXX Health anti-aging and rejuvenation clinics.
공지 • Jun 21Full Alliance Group, Inc. Announces Appointment of Dr. Richard Marc Goldfarb to Medical Advisory BoardFull Alliance Group, Inc. has announced the appointment of Dr. Richard Goldfarb to their medical advisory board. He brings with him over 30 years of experience as a board-certified surgeon and a valuable aesthetics background that will inform and advance the rejuvenative healthcare efforts of the Company, overseeing the clinical studies of its new line of supplements, Natural Powers, and supporting its work on EBO2 protocol. Dr. Goldfarb's extensive clinical experience and research in cosmetics, aesthetics, and surgery will bring a new perspective and innovative ideas to the Company's preventative healthcare technology and nutritional product offerings. FAGI is excited about his input on quality supplement formulas and the aesthetic expertise he will add to acquisition efforts. His long history as a medical director, in addition to his cutting-edge approaches to health enhancement techniques, will provide the Company with a distinct advantage. Dr. Goldfarb will be instrumental in the Company's launch of its Natural Powers ("NP") brand. All supplements and topicals in the NP brand will have clinical studies and will be published in prestigious journals. The initial products in the NP brand will be sleep, immunity, focus, weight loss, and pain. Dr. Goldfarb will be working closely with Steve Kusher, the Company's master formulator, on the formulation of these products. The Company is expecting the first clinical study to begin in third quarter 2023, with the first product being Natural Powers - Sleep.Dr. Goldfarb graduated from the Chicago Medical School with top honors in surgery and completed surgical training at Northeastern Ohio College of Medicine, a Division of the Cleveland Clinic. He received specialized cosmetic surgery training from the University of Pennsylvania'sDepartment of Plastic Surgery and Yale University. He also holds certifications in Advanced Cardiac Life Support Aesthetic Advancements, a certificate from the American Academy of Cosmetic Physicians, and is a long-time Fellow of the American College of Surgeons, among several other accreditations. Currently, Dr. Goldfarb is the medical director for major companies, Benev, and Selphyl.Past Medical Director for The Silhouette Lift, and Viora™. He is also a scientific advisory board member and lecturer for The Aesthetics Show and holds prominent professional society memberships with The American Society of Lasers in Medicine, the American Academy of Liposuction Surgery, the American Academy of Cosmetic Surgery, and many more. Major recognitions that Dr. Goldfarb has garnered include an EmSculpt Ambassador Award from BTL Aesthetics and is currently on the Medical Advisory Board, an award from the Philippine Academy of Aesthetic and Age Management, a recipient of "The Best Surgical Body Shaping" award, and numerous others throughout his long career. He is also the Chief Executive Officer and founder of Progressive Men's Health and is a founding board member, faculty member, and lecturer for the National Society of Cosmetic Physicians, for which he chaired an annual meeting hosting hundreds of physicians from around the globe.